Fmr Llc

13F Holdings History for Taysha Gene Therapies, Inc. - Common Stock, $0.00001 par value (TSHA)

Symbol: TSHA on Nasdaq
Investment type: Equity / Common Stock, $0.00001 par value
Latest Disclosed Ownership: 15.6M shares
Security Ownership: 6.2%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA)

2025-08-06 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 15.6M shares of Taysha Gene Therapies, Inc. Common Stock, $0.00001 par value (TSHA). This represents 6.2% percent ownership of the company. In their previous filing dated 2025-02-12, FMR LLC had reported owning 16.4M shares, indicating a decrease of -4.51% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	6.2%	-22.5%	$36.3M	15.6M	-737,842	-4.51%	$2.32	13G/A	6/30/2025	6 Aug 2025 12:14:18
FMR LLC	8%		$20.5M	16.4M			$1.25	13G/A	12/31/2024	12 Feb 2025 09:22:54

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0%	0%	$47.7M	14.6M	-1,034,410	-6.62%	$3.27	Q3 2025
6/30/2025	0%	0%	$36.1M	15.6M	-4,132	-0.03%	$2.31	Q2 2025
3/31/2025	0%	0%	$21.7M	15.6M	-733,710		$1.39	Q1 2025
12/31/2024	0%	0%	$28.3M	16.4M	-2,312,863	-12.4%	$1.73	Q4 2024
9/30/2024	0%	0%	$37.5M	18.7M	-2,532,109	-11.9%	$2.01	Q3 2024
6/30/2024	0%	+0%	$47.5M	21.2M	+1,099,919	+5.47%	$2.24	Q2 2024
3/31/2024	0%	0%	$57.7M	20.1M	-2,328,407	-10.4%	$2.87	Q1 2024
12/31/2023	0%	0%	$39.7M	22.4M	-2,088,677	-8.52%	$1.77	Q4 2023
9/30/2023	0.01%	+0.01%	$77.5M	24.5M	+23,378,974	+2035%	$3.16	Q3 2023
6/30/2023	0%	0%	$759K	1.15M	-1,938,511	-62.8%	$0.66	Q2 2023
3/31/2023	0%	0%	$2.46M	3.09M	-117,584	-3.67%	$0.80	Q1 2023
12/31/2022	0%	0%	$7.24M	3.2M	-80,861	-2.46%	$2.26	Q4 2022
9/30/2022	0%	0%	$6.34M	3.29M	-9,898	-0.3%	$1.93	Q3 2022
6/30/2022	0%		$12.3M	3.3M	+860	+0.03%	$3.72	Q2 2022
3/31/2022	0%	0%	$21.5M	3.29M	-985,673	-23%	$6.52	Q1 2022
12/31/2021	0%	0%	$49.9M	4.28M	-1,478,180	-25.7%	$11.65	Q4 2021
9/30/2021	0.01%	+0%	$107M	5.76M	+71,058	+1.25%	$18.62	Q3 2021
6/30/2021	0.01%	+0%	$121M	5.69M	+23,401	+0.41%	$21.20	Q2 2021
3/31/2021	0.01%		$115M	5.66M			$20.30	Q1 2021
12/31/2020	0.01%	+0%	$148M	5.66M	+1,456,641	+34.6%	$26.10	Q4 2020
9/30/2020	0.01%	+0.01%	$90.1M	4.21M	+4,207,574	NEW	$21.41	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.